Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | AMGN | REGN | VRTX | GILD |
| Company | Dicerna Pharmaceutic | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 38.21 | 298.23 | 558.39 | 476.49 | 113.54 |
| High | 38.24 | 299.91 | 568.46 | 478.27 | 113.81 |
| Low | 38.21 | 294.00 | 551.48 | 467.97 | 109.45 |
| Last | 38.22 | 295.27 | 567.74 | 468.85 | 109.64 |
| Change | +0.22 | -5.10 | +7.98 | -10.68 | -4.90 |
| % Change | +0.58% | -1.70% | +1.43% | -2.23% | -4.28% |
| Volume | 5,568,900 | 1,619,900 | 844,600 | 892,800 | 6,116,200 |
| 20-Day Average Volume | 3,647,665 | 2,771,080 | 1,010,675 | 1,274,220 | 8,246,930 |
| Previous Close | 38.00 | 300.37 | 559.76 | 479.53 | 114.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 289.53 | 531.17 | 454.46 | 110.05 |
| 20-Day Raw Stochastic | 90.72% | 79.42% | 98.90% | 67.10% | 49.76% |
| 20-Day Relative Strength | 80.40% | 54.82% | 56.53% | 56.00% | 50.67% |
| Weighted Alpha | +35.17 | -7.82 | -46.71 | -2.26 | +48.73 |
| Today's Opinion | 88% Buy | 8% Buy | 56% Sell | 8% Buy | 72% Buy |
| Previous Opinion | 72% Buy | 8% Buy | 56% Sell | 24% Buy | 88% Buy |
| Last Month's Opinion | 24% Buy | 24% Sell | 100% Sell | 56% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | -1.00% since 07/03/25 | +3.72% since 07/03/25 | +2.01% since 07/03/25 | -1.89% since 07/03/25 |
| Low | 37.81 on 12/21/21 | 291.25 on 07/08/25 | 532.60 on 07/07/25 | 455.79 on 07/07/25 | 109.45 on 07/11/25 |
| High | 38.24 on 12/27/21 | 302.38 on 07/10/25 | 568.46 on 07/11/25 | 484.56 on 07/10/25 | 114.87 on 07/10/25 |
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | +1.19% since 06/11/25 | +9.48% since 06/11/25 | +3.63% since 06/11/25 | +0.31% since 06/11/25 |
| Low | 37.78 on 12/10/21 | 267.83 on 06/23/25 | 503.25 on 06/18/25 | 436.80 on 06/20/25 | 104.46 on 06/25/25 |
| High | 38.26 on 12/03/21 | 302.38 on 07/10/25 | 568.46 on 07/11/25 | 484.56 on 07/10/25 | 114.87 on 07/10/25 |
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | +3.25% since 04/11/25 | +2.45% since 04/11/25 | -3.17% since 04/11/25 | +5.80% since 04/11/25 |
| Low | 19.06 on 10/06/21 | 261.43 on 05/14/25 | 476.49 on 06/05/25 | 416.60 on 05/14/25 | 93.37 on 04/25/25 |
| High | 38.26 on 12/03/21 | 302.38 on 07/10/25 | 617.52 on 05/21/25 | 510.77 on 04/30/25 | 114.87 on 07/10/25 |
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | +12.60% since 01/10/25 | -18.53% since 01/10/25 | +14.48% since 01/10/25 | +21.98% since 01/10/25 |
| Low | 19.06 on 10/06/21 | 261.28 on 01/13/25 | 476.49 on 06/05/25 | 397.24 on 01/13/25 | 89.02 on 01/13/25 |
| High | 40.14 on 07/20/21 | 335.88 on 03/10/25 | 748.29 on 03/10/25 | 519.68 on 03/14/25 | 119.96 on 03/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 158,768,448 | 61,296,040 | 120,399,272 | 136,384,368 |
| Shares Outstanding, K | 78,129 | 537,706 | 107,965 | 256,797 | 1,243,929 |
| Annual Sales | 164,310,000 | 33,424,000,000 | 14,202,000,000 | 11,020,100,000 | 28,754,000,000 |
| Annual Net Income | -112,750,000 | 4,090,000,000 | 4,412,600,000 | -535,600,000 | 480,000,000 |
| Last Quarter Sales | 62,950,000 | 8,149,000,000 | 3,028,700,000 | 2,770,200,000 | 6,667,000,000 |
| Last Quarter Net Income | -17,070,000 | 1,730,000,000 | 808,700,000 | 646,300,000 | 1,315,000,000 |
| 60-Month Beta | 0.80 | 0.49 | 0.33 | 0.41 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | 4.90 on 05/01/25 | 8.22 on 04/29/25 | 4.06 on 05/05/25 | 1.81 on 04/24/25 |
| Latest Earnings Date | 11/09/21 | 08/05/25 | 08/01/25 | 08/04/25 | 08/14/25 |
| Most Recent Dividend | N/A | 2.380 on 05/16/25 | 0.880 on 05/20/25 | N/A | 0.790 on 06/13/25 |
| Next Ex-Dividends Date | N/A | 05/16/25 | 05/20/25 | N/A | 06/13/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.47 | 14.67 | 0.00 | 14.80 |